Viemed Healthcare, Inc. (VMD)
USD 6.59
(0.92%)
USD 6.59
(0.92%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 154.1 Million USD | 31.66% |
| 2022 | 117.04 Million USD | -0.78% |
| 2021 | 117.96 Million USD | 4.8% |
| 2020 | 112.56 Million USD | 36.28% |
| 2019 | 82.59 Million USD | 54.31% |
| 2018 | 53.52 Million USD | 42.01% |
| 2017 | 37.69 Million USD | 52.72% |
| 2016 | 24.67 Million USD | 10.11% |
| 2015 | 22.41 Million USD | 120.84% |
| 2014 | 10.14 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 154.87 Million USD | 0.5% |
| 2024 Q2 | 163.94 Million USD | 5.86% |
| 2023 Q2 | 149.11 Million USD | 19.64% |
| 2023 Q3 | 149.4 Million USD | 0.19% |
| 2023 FY | 154.1 Million USD | 31.66% |
| 2023 Q1 | 124.63 Million USD | 6.49% |
| 2023 Q4 | 154.1 Million USD | 3.15% |
| 2022 Q4 | 117.04 Million USD | -1.99% |
| 2022 FY | 117.04 Million USD | -0.78% |
| 2022 Q1 | 119 Million USD | 0.89% |
| 2022 Q2 | 115.9 Million USD | -2.61% |
| 2022 Q3 | 119.41 Million USD | 3.03% |
| 2021 Q3 | 115.48 Million USD | 4.03% |
| 2021 Q4 | 117.96 Million USD | 2.14% |
| 2021 FY | 117.96 Million USD | 4.8% |
| 2021 Q1 | 113 Million USD | 0.39% |
| 2021 Q2 | 111.01 Million USD | -1.76% |
| 2020 FY | 112.56 Million USD | 36.28% |
| 2020 Q4 | 112.56 Million USD | -1.24% |
| 2020 Q3 | 113.96 Million USD | 1.6% |
| 2020 Q2 | 112.17 Million USD | 29.24% |
| 2020 Q1 | 86.8 Million USD | 5.09% |
| 2019 Q1 | 58.58 Million USD | 9.45% |
| 2019 Q4 | 82.59 Million USD | 3.4% |
| 2019 Q2 | 70.88 Million USD | 21.0% |
| 2019 Q3 | 79.88 Million USD | 12.69% |
| 2019 FY | 82.59 Million USD | 54.31% |
| 2018 Q2 | 44.16 Million USD | 8.88% |
| 2018 FY | 53.52 Million USD | 42.01% |
| 2018 Q1 | 40.56 Million USD | 7.63% |
| 2018 Q3 | 49.14 Million USD | 11.27% |
| 2018 Q4 | 53.52 Million USD | 8.91% |
| 2017 Q3 | 32.74 Million USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 FY | 37.69 Million USD | 52.72% |
| 2017 Q4 | 37.69 Million USD | 15.12% |
| 2016 Q4 | 24.67 Million USD | 0.0% |
| 2016 FY | 24.67 Million USD | 10.11% |
| 2015 FY | 22.41 Million USD | 120.84% |
| 2014 FY | 10.14 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| PetVivo Holdings, Inc. | 3.11 Million USD | -4846.709% |
| Talis Biomedical Corporation | 98.34 Million USD | -56.704% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -1903.413% |
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -391.304% |
| Bioventus Inc. | 810.91 Million USD | 80.996% |
| Cerus Corporation | 197.74 Million USD | 22.071% |
| CVRx, Inc. | 115.22 Million USD | -33.736% |
| electroCore, Inc. | 16.38 Million USD | -840.395% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -162.7% |
| OrthoPediatrics Corp. | 449.58 Million USD | 65.723% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -465.099% |
| Spectral AI, Inc. | 10.69 Million USD | -1341.288% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -829.504% |
| BrainsWay Ltd. | 62.97 Million USD | -144.716% |
| Envoy Medical, Inc. | 7.64 Million USD | -1917.049% |
| MaxCyte, Inc. | 268.27 Million USD | 42.558% |
| NanoVibronix, Inc. | 6.67 Million USD | -2208.998% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 29.52% |
| Nexalin Technology, Inc. | 3.63 Million USD | -4143.009% |
| Orthofix Medical Inc. | 925.31 Million USD | 83.346% |
| Inogen, Inc. | 326.19 Million USD | 52.757% |
| IceCure Medical Ltd | 16.41 Million USD | -839.077% |
| PAVmed Inc | 33.11 Million USD | -365.299% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -558.598% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -7.424% |
| RxSight, Inc. | 182.55 Million USD | 15.583% |
| Sight Sciences, Inc. | 166.65 Million USD | 7.53% |
| SI-BONE, Inc. | 230.42 Million USD | 33.122% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -1803.131% |
| TELA Bio, Inc. | 78.04 Million USD | -97.446% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -499.038% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 38.826% |
| Venus Concept Inc. | 93.65 Million USD | -64.545% |
| Acutus Medical, Inc. | 53.96 Million USD | -185.587% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -1336.184% |
| LivaNova PLC | 2.42 Billion USD | 93.657% |
| 908 Devices Inc. | 202.98 Million USD | 24.08% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 80.862% |
| Nemaura Medical Inc. | 14.56 Million USD | -958.161% |
| NeuroPace, Inc. | 107.65 Million USD | -43.15% |
| LENSAR, Inc. | 69.58 Million USD | -121.459% |
| Apyx Medical Corporation | 79.24 Million USD | -94.476% |
| Cutera, Inc. | 346.29 Million USD | 55.499% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -266.771% |
| BioSig Technologies, Inc. | 1.79 Million USD | -8470.774% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 43.058% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -261.226% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 95.925% |
| Axonics, Inc. | 719.92 Million USD | 78.595% |
| Outset Medical, Inc. | 313.8 Million USD | 50.892% |
| IRIDEX Corporation | 34.43 Million USD | -347.504% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 61.923% |
| IRadimed Corporation | 92.15 Million USD | -67.219% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -2833.051% |
| INVO Bioscience, Inc. | 20.88 Million USD | -637.764% |
| Telesis Bio, Inc. | 70.41 Million USD | -118.861% |
| Varex Imaging Corporation | 1.24 Billion USD | 87.668% |
| Quipt Home Medical Corp. | 247.4 Million USD | 37.713% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1555.236% |
| Pulmonx Corporation | 178.95 Million USD | 13.886% |
| Dynatronics Corporation | 25.94 Million USD | -494.06% |
| Modular Medical, Inc. | 13.8 Million USD | -1016.119% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -1336.585% |
| Semler Scientific, Inc. | 78.06 Million USD | -97.403% |
| InMode Ltd. | 863.28 Million USD | 82.149% |
| Bruker Corporation | 4.24 Billion USD | 96.374% |
| Cytosorbents Corporation | 53.26 Million USD | -189.337% |
| DexCom, Inc. | 6.26 Billion USD | 97.54% |
| Align Technology, Inc. | 6.08 Billion USD | 97.467% |
| Viveve Medical, Inc. | 25.91 Million USD | -494.692% |
| ZimVie Inc. | 1.2 Billion USD | 87.215% |
| Movano Inc. | 9.42 Million USD | -1535.734% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 69.035% |
| Nexalin Technology, Inc. | 3.63 Million USD | -4143.009% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -162.7% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 83.824% |
| Profound Medical Corp. | 43.68 Million USD | -252.748% |
| Insulet Corporation | 2.58 Billion USD | 94.046% |
| enVVeno Medical Corporation | 48.63 Million USD | -216.855% |
| Surmodics, Inc. | 185.73 Million USD | 17.03% |
| iCAD, Inc. | 41.41 Million USD | -272.067% |
| Nuwellis, Inc. | 9.77 Million USD | -1477.303% |
| Biotricity, Inc. | 5.94 Million USD | -2493.172% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 64.422% |
| Aethlon Medical, Inc. | 8.24 Million USD | -1768.819% |
| InspireMD, Inc. | 47.64 Million USD | -223.453% |
| PAVmed Inc. | 33.11 Million USD | -365.299% |
| BIOLASE, Inc. | 35.1 Million USD | -339.026% |
| Beyond Air, Inc. | 56.96 Million USD | -170.54% |
| FONAR Corporation | 214.24 Million USD | 28.072% |
| AxoGen, Inc. | 196.82 Million USD | 21.707% |
| Vivani Medical, Inc. | 45.79 Million USD | -236.49% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 45.245% |
| Inari Medical, Inc. | 674.23 Million USD | 77.144% |
| UFP Technologies, Inc. | 404.13 Million USD | 61.869% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -1521.6% |
| Tenon Medical, Inc. | 6.34 Million USD | -2328.724% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -1538.168% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -48.679% |
| AdaptHealth Corp. | 4.61 Billion USD | 96.664% |
| Sintx Technologies, Inc. | 15.36 Million USD | -902.945% |
| Quanterix Corporation | 425.01 Million USD | 63.742% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1555.236% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -186.825% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 91.174% |
| TransMedics Group, Inc. | 706.04 Million USD | 78.174% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -143.864% |
| NeuroMetrix, Inc. | 21.42 Million USD | -619.284% |
| Hyperfine, Inc. | 94.19 Million USD | -63.593% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 42.636% |
| Biomerica, Inc. | 9.25 Million USD | -1565.253% |
| Bone Biologics Corporation | 3.73 Million USD | -4022.854% |
| AVITA Medical, Inc. | 144.33 Million USD | -6.764% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -3065.277% |
| Silk Road Medical, Inc | 265.3 Million USD | 41.916% |